Europe’s Nicotine Policy Challenge: Finding Common Ground Through Evidence

Across Europe, governments are navigating one of the most complex public health challenges of our time: how to regulate emerging nicotine products while protecting youth, safeguarding consumers, and achieving long-term health goals. At the Global Institute for Novel Nicotine (GINN), we recognize that these concerns are legitimate. Our goal is not to challenge regulation, but…

FDA Moves to Fast-Track Nicotine Pouch Reviews Under White House Pressure

The U.S. Food and Drug Administration (FDA) is accelerating its review of nicotine pouches, responding to mounting pressure from the White House to clarify the regulatory status of one of the fastest-growing categories in tobacco harm reduction. A Rapidly Expanding Market in Limbo Nicotine pouches, tobacco-free oral sachets delivering nicotine without combustion, have surged in…

FDA Strengthens Packaging Rules for Nicotine Products: Why Child Safety Matters

The U.S. Food and Drug Administration (FDA) has announced strengthened requirements for child-resistant packaging (CRP) on nicotine products, underscoring the critical importance of safeguarding children while balancing access for adult smokers seeking reduced-risk alternatives. The decision comes amid rising concerns about accidental ingestion of nicotine pouches, e-liquids, and other smoke-free products. Although these products pose…

Expert Coalition Voices Alarm Over EU’s Proposed Nicotine Tax Shift

A coalition of 83 distinguished global authorities in public health, nicotine dependence, and tobacco control has issued a forceful open letter to the President of the European Commission and Commissioners. Their unified message: imposing steep new taxes on reduced-risk nicotine alternatives, such as e-cigarettes, heated tobacco, and nicotine pouches, would be a grave misstep. They…

AFN25: Asia’s Moment to Reframe Tobacco Harm Reduction

Contribution from Nancy Loucas The inaugural Asia Forum on Nicotine (AFN25), hosted by the Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) on 27 August, was a resounding success. The event drew together global experts, advocates, and consumers to champion evidence-based harm reduction strategies tailored to the Asia-Pacific region’s staggering 781 million tobacco users,…

A Regulatory Journey of Modern Oral Nicotine Across Asia

Asia, the world’s largest consumer of combustible tobacco, is becoming a critical region in shaping the regulatory future of nicotine pouches and other smoke-free products. As governments across the continent respond to rising demand for safer nicotine alternatives, the picture that emerges is far from uniform. Regulations range from strict prohibitions and pharmaceutical-style oversight to…